×
Atai Life Sciences EBIT 2020-2024 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atai Life Sciences ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Atai Life Sciences EBIT 2020-2024 | ATAI
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Atai Life Sciences ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$20.6B
Quest Diagnostics (DGX)
$17.4B
DaVita (DVA)
$12.3B
Encompass Health (EHC)
$10.4B
Chemed (CHE)
$8.3B
Elanco Animal Health (ELAN)
$7.2B
RadNet (RDNT)
$5.3B
Option Care Health (OPCH)
$3.9B
Amedisys (AMED)
$3.2B
LifeStance Health (LFST)
$2.9B
Astrana Health (ASTH)
$2.9B
Addus HomeCare (ADUS)
$2.3B
U.S Physical Therapy (USPH)
$1.4B
Pennant (PNTG)
$1.1B
Aveanna Healthcare Holdings (AVAH)
$1.1B
Daxor (DXR)
$45M
MEDIROM Healthcare Technologies (MRM)
$14M
Psychemedics (PMD)
$14M
ATI Physical Therapy (ATIP)
$13M
Ontrak (OTRK)
$8M
IMAC Holdings (BACK)
$1M